CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Altre lingue Chongqing Zhifei Biological Products Co., Ltd.

Azioni

300122

CNE100000V20

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 09/07/2024			Variaz. 5gg	Var. 1 gen.
26,08 ^CNY	+0,08%		-5,58%	-57,32%

23/04	L'utile di Chongqing Zhifei Biological Products per il 2023 aumenta del 7%; le azioni crollano del 12%	MT
22/04	Chongqing Zhifei Biological Products Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2023	19/06
Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%	23/04
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.	28/03
Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback announced on February 22, 2024, has closed with 6,210,253 shares, for CNY 300.01 million.	28/03
Chongqing Zhifei Biological Products Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	22/02
Chongqing Zhifei Biological Products Co., Ltd. authorizes a Buyback Plan.	22/02
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11/01
Wordt de CSI A50 de beste Chinese index?	05/01
¿Se convertirá el CSI A50 en el mejor índice chino?	03/01
Zhifei Biological Products to Acquire Local Biopharma Firm, Expanding Into Metabolic Disease Treatments	27/11
Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.	23/11
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Middle East Conflict Weighs on Exchange-Traded Funds, Equity Futures Pre-Bell Monday	09/10/23
GSK Signs Distribution Deal With China's Zhifei for Shingles Vaccine	09/10/23
Chongqing Zhifei Biological Enters Exclusive Distribution Deal With GSK	09/10/23
MIDDAY BRIEFING - Unternehmen und Märkte	09/10/23
Trending : GSK Signs $3 Billion Shingles Vaccine Deal in China	09/10/23
GSK schließt Abnahmevertrag für Gürtelrose-Impfstoff in China über 2,5 Mrd Pfund	09/10/23
GSK Strikes $3.06 Billion Shingles Vaccine Deal With China's Zhifei -- Update	09/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Chongqing Zhifei Biological Products Co., Ltd.

Azioni

300122

CNE100000V20

Altre lingue

Filtri